2019/2826(RSP) Resolution on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron
Lead committee dossier:
Progress: Awaiting Parliament 1st reading / single reading / budget 1st stage
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | HAZEKAMP Anja ( GUE/NGL) | TRILLET-LENOIR Véronique ( Renew) |
Lead committee dossier:
Legal Basis:
RoP 112-p2
Legal Basis:
RoP 112-p2Events
2019/10/10
Vote in plenary scheduled
2019/09/12
EP - HAZEKAMP Anja (GUE/NGL) appointed as rapporteur in ENVI
Activities
Votes
B9-0104/2019 - Proposition de résolution #
2019/10/10 Outcome: +: 417, -: 200, 0: 40
History
(these mark the time of scraping, not the official date of the change)
2019-10-11Show (1) Changes | Timetravel
forecasts/0/title |
Old
Vote in plenary scheduledNew
Vote scheduled |
2019-10-10Show (2) Changes
forecasts/0/title |
Old
Indicative plenary sitting date, 1st reading/single readingNew
Vote in plenary scheduled |
procedure/title |
Old
Objection pursuant to Rule 112: Extension of the approval periods of the active substances amidosulfuron, beta cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (D062951)New
Resolution on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron |